V63A (p.Val63Ala) variant of SLC40A1 (Ferroportin)

V63A (p.Val63Ala) in SLC40A1 (Ferroportin) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely pathogenic in the context of Hemochromatosis type 4. The available variant effect predictions contribute to a CATVariant prioritization score of 0.71 / 1. The record also includes structural context.

V63A (p.Val63Ala) variant details